Connect with us

Awareness

Facts About Depression and ADHD That Your Doctor Probably Doesn’t Even Know About

Published

on

*This is a re-post combination of two of our previous articles. The first half deals with ADHD and the second half deals with depression

advertisement - learn more

Putting a child in a classroom for 8 hours a day, for more than a decade, and expecting them to listen while remaining ‘obedient’ is very unrealistic. From day one we are taught that this is the only path to success and we are shown the consequences of not paying attention. It’s important to recognize that it’s perfectly normal for children to struggle with paying attention to something that they are not even remotely interested in; this doesn’t necessarily mean they have a disorder and it doesn’t mean they require (potentially quite harmful) prescription medications.

It’s Okay If Your Child Struggles With Attention – This Does’t Mean They Have A Disorder

Many doctors and teachers are already aware of this, but I would like to reiterate the point — just because your child struggles with paying attention in school or sitting still in the classroom does not mean there is an underlying disorder to blame. It’s perfectly natural for your child to want to be active and to want to focus on things which actually interest them. Sure, low grades might come as a result of not paying attention, but it is possible for a 2.0 student to know more than a 4.0 student; grades don’t necessarily equate with intelligence. In many cases, they reflect an ability to follow rules and memorize information — both important skills, but perhaps less important than critical thinking and creativity.  Some students may have a better ability to buckle down, pay attention, and do their work, while other, equally as intelligent students, may struggle with this model. This, again, is perfectly normal, and could actually be a marker of something really positive. If your child is being held back and being denied even the possibility of entering a gifted program based on the fact that they have attention issues, then there is problem.

New data from the National Center for Learning Disabilities shows that only 1 percent of students who receive services for their apparent learning disabilities (some of which are completely and unquestionably valid) are enrolled in gifted or talented programs. The report concluded that “students with learning and attention issues are shut out of gifted and AP programs, held back in grade level and suspended from school at higher rates than other students.” (source)

Disorder Or Creativity?

The last point in the above paragraph is pretty disturbing, particularly given the fact that recent work in cognitive neuroscience shows us that both those with an ADHD diagnosis, and creative thinkers, have difficulty in suppressing brain activity that comes from the  “Imagination Network.” There are no school assessments to evaluate creativity and imagination; these are admittedly difficult to measure and, accordingly, receive very little attention in the education system. Yet a lot of research is pointing to the fact that people who show characteristics of ADHD are more likely to reach higher levels of creative thought and achievement compared to those who don’t show these characteristics.

“By automatically treating ADHD characteristics as a disability– as we so often do in an educational context– we are unnecessarily letting too many competent and creative kids fall through the cracks.” – Scott Barry Kaufman, Scientific Director of The Imagination Institute in the Positive Psychology Center at the University of Pennsylvania (source)

advertisement - learn more

While brain scans of people diagnosed with ADHD do show structural differences, it is a scary reality that a large portion of ADHD diagnoses are derived from the observations teachers make in school. Too often, children are diagnosed based on perceived behaviour alone, and then encouraged to take medication right away. These children are not actually tested or scanned; they and their parents are simply told that they have ADHD.

“I think the big mistake in schools is trying to teach children anything, and by using fear as the basic motivation. Fear of getting failing grades, fear of not staying with your class, etc. Interest can produce learning on a scale compared to fear as a nuclear explosion to a firecracker.” – Stanley Kubrick

Did They Tell You This About The Pharmaceutical Industry?

ADHD

The quote to your left comes from Harvard Medical professor and the former Editor-in-Chief of The New England Journal of Medicine, Dr. Marcia Angell. She joins a long and growing list of some very ‘credible’ people within the medical profession who are trying to tell the world something important. She has said on several occasions that it is no longer possible to believe much of the published research, or even to rely on the judgement of trusted physicians or authoritative medical guidelines. (source)

Another great example is Dr. Richard Horton, who is currently the Editor-in-Chief of The Lancet, which is considered to be one of the top ranked medical journals in the world. He said that “the case against science is straightforward, much of the scientific literature, perhaps half, may simply be untrue. . . . Science has taken a turn towards darkness.”  (source)

The reason why these professionals are saying such things is because, as Dr. Angell puts it, “the pharmaceutical industry likes to depict itself as a research-based industry, as the source of innovative drugs. Nothing could be further from the truth. This is their incredible PR and their nerve.”

“The medical profession is being bought by the pharmaceutical industry, not only in terms of the practice of medicine, but also in terms of teaching and research. The academic institutions of this country are allowing themselves to be the paid agents of the pharmaceutical industry. I think it’s disgraceful.” – Arnold Seymour Relman, Harvard Professor of Medicine

The percentage of children with an ADHD diagnosis continues to increase; it went from 7.8 percent in 2003 all the way up to 11.0 percent in 2011. According to a recent analysis, ADHD in children has surged by 43 percent since 2003. (source)

The quotes above aren’t just opinions, clearly these few (out of many) examples are from people who know a thing or two about the industry, and it is troublesome to think that people still believe pharmaceutical corruption and manipulation of scientific literature are conspiracy theories.

The most recent real world example of this comes from a few months ago, when an independent review found that the commonly prescribed antidepressant drug Paxil is not safe for teenagers — all after the fact that a large amount of literature had previously suggested this. The 2001 drug trial that took place, funded by GlaxoSmithKline (also maker of the Gardasil Vaccine), found that these drugs were completely safe, and used that ‘science’ to market Paxil as safe for teenagers. The study came from John Ioannidis, an epidemiologist at the Stanford University School of Medicine.

Ioannidis is also the author of the most widely accessed article in the history of the Public Library of Science (PLoS), titled “Why Most Published Research Findings Are False.” In the report, he stated that most current published research findings are false. And this was more than 10 years ago.

ADHD is classified as a mental disorder, which is interesting because the definition of these types of disorders in particular have been shown to be heavily influenced by the pharmaceutical industry. American psychologist Lisa Cosgrove and others investigated financial ties between the Diagnostic and Statistical Manual of Mental Disorders (DSM) panel members and the pharmaceutical industry. They found that, of the 170 DSM panel members, 95 (56%) had one or more financial associations with companies in the pharmaceutical industry. One hundred percent of the members of the panels on ‘mood disorders’ and ‘schizophrenia and other psychotic disorders’ had financial ties to drug companies. The connections are especially strong in those diagnostic areas where drugs are the first line of treatment for mental disorders. In the next edition of the manual, it’s the same thing.

“The DSM appears to be more a political document than a scientific one. Each diagnostic criteria in the DSM is not based on medical science. No blood tests exist for the disorders in the DSMN. It relies on judgements from practitioners who rely on the manual.” – Lisa Cosgrove, PhD, Professor of Counselling and School Psychology at the University of Massachusetts, Boston

The very vocabulary of psychiatry is now defined at all levels by the pharmaceutical industry.” – Dr. Irwin Savodnik, an Assistant Clinical Professor of Psychiatry at the University of California at Los Angeles (source)

These are definitely some facts to take into consideration when it comes to dealing with your child’s ADHD diagnosis. It’s a ‘disease’ — one which I was also diagnosed with — that I personally don’t even think is real. I think it was made up strictly for the purpose of making money.

There Are Other Methods To Help Your Child Focus & Improve Your Child’s Ability To Pay Attention

It’s becoming clear that we need a new approach to ADHD. Apart from examining the truth behind that label, as I hope I have done in the above paragraphs, it’s important to note that there does not appear to be much room in our school system for children who do not fit the ‘normal’ mould of the majority. The fact that we basically point a finger at them and label them does not really help anything. As much as we’ve been marketed to believe that medication can help solve the problem, I really believe they only worsen it. Many of these medications seem to dull the emotions and energy of the children taking them, ultimately making for a less positive and rich life experience.

One great way to improve your child’s ability to focus is to change their diet. It’s a shame that hardly any research has been published examining the relationship between mental ‘disabilities’  and diet, since many medical professionals strongly believe there is a direct link between them. Some studies have, indeed, emerged which show a link between a gluten/casein free diet and improvement in autistic symptoms, and some parents have already seen the benefits of implementing this research. (source)

The Mayo Clinic claims that certain food preservatives and colourings could increase hyperactive behaviour in some children. It would be best to avoid these, regardless of whether they are linked to ADHD or not.

It has also been suggested that EEG biofeedback (electroencephalographic) could help. It’s a type of neurotherapy that measures brainwaves. You can read more about that here.

In 2003, a study published in the journal Adolescence looked at how regular massages for 20 minutes twice a week could improve behaviour in the classroom. This is interesting because studies have also suggested that tai chi and yoga may also help improve ADHD symptoms. According to the studies, children with ADHD that practiced tai chi became less anxious or hyperactive. (source)

So, one thing you could try is observing what your child is eating. You can limit their intake of harmful, hormone disrupting, disease causing foods like sugar, limit their exposure to pesticides, and encourage their consumption of fruits, vegetables, and whole foods (rather than processed foods).

When it comes down to it, developing methods for your child to pay attention to something they find boring and/or useless is a difficult task, and for parents who struggle with this, it’s important to remember that most likely your child is perfectly normal. It will help to choose to look at it in a positive light.

The fact that children are forced into these institutions, told how the world works, made to follow certain rules, and pressured to complete education out of fear of not having a job, is a truly unfortunate reality of today’s world. It is not the best environment for a child. Perhaps things will change in the future, but right now it seems children are encouraged to complete education out of fear, out of necessity, and out of the mentality that “this is just the way the world is.”

“When we can’t say ‘No,’ we become a sponge for the feelings of everyone around us and we eventually become saturated by the needs of everyone else while our own hearts wilt and die. We begin to live our lives according to the forceful should of others, rather than the whispered, passionate want of our own hearts. We let everyone else tell us what story to live and we cease to be the author of our own lives. We lose our voice — we lose the desire planted in our souls and the very unique way in which we might live out that desire in the world. We get used by the world instead of being useful in the world.” – Dr. Kelly M. Flanagan, a licensed clinical psychologist, Ph.D. in clinical psychology (source)

Perhaps sitting down and talking to your child, letting them know that there is nothing wrong with them and that they don’t have a ‘disorder’ is a good start, at least for those who have already been labeled. Again, just because one person struggles with paying attention does not mean they have a disorder. If the information above is any indication, it could actually mean the opposite.

Having your child even believe in that type of label could be harmful. Given the recent developments in neuroplasticity and parapsychology, it has become clear that how a person thinks alone can change their biology.

Speaking with educators and finding a differentiated type of instruction more tailored to your child’s needs and interests could also be a solution. One of the biggest solutions, in my opinion, is not accepting labels for your children in the first place.

This is a big problem in modern day education, and solutions are limited. The issue here really seems to be the environment the children are surrounded by, not the children themselves.

Another thing parents could address are the feelings of the child. Part of growing up is learning to handle our emotions and tackle whatever challenges life throws at us, but in school we are only taught content, and that is all we seem to focus on. Humans are made up of more than just bits of learned information; we all perceive a certain way and if emotions and thoughts are not openly discussed and dealt with, it can create problems in other areas.

“I don’t know about you, but in my adult life, I have never had to use geometry once… yet I experience emotions and challenges every day. If school is designed to prepare you for life… why not teach actual life skills?” – Elina St. Onge

Depression, Chemical Imbalance or Not?

Is the chemical imbalance theory of depression really true, or is it just a tool used to push more drugs onto the market? After all, antidepressant drugs are the most commonly prescribed drugs in North America. Pharmaceutical companies are bringing in billions of dollars every single year from the sale of antidepressant drugs alone, and they also spend billions of dollars marketing and advertising their products.

Joseph Coyle, a neuroscientist from Harvard Medical School, sums it up best, writing that “chemical imbalance is sort of last-century thinking. It’s much more complicated than that.” And it’s true; depression is much more complicated than that, at least compared to the commonly accepted belief that depression results from a chemical imbalance in the brain. This idea was posed in the late 1950s and has since taken hold in everyone’s minds. It’s the general idea that a deficiency of select neurotransmitters exists (chemical messengers) at critical points, like synapses. One of these neurotransmitters, for example, is serotonin; others include norepinephrine and dopamine.

As Scientific American reports, “much of the general public seems to have accepted the chemical imbalance hypothesis uncritically,” and that “it is very likely that depression stems from influences other than neurotransmitter abnormalities.” (source)

Harvard Medical School put out a press release a few years ago stating that it’s “often said that depression results from a chemical imbalance, but that figure of speech doesn’t capture how complex the disease is.”  (source)

Of course, there are brain events and biochemical reactions occurring when someone feels depressed, as there are all the time, but no research has ever established that a particular brain state causes, or even correlates with, depression. . . . In all cases studies yield inconsistent results, and none have been shown to be specific to depression, let alone causal.

The fact that more than 50 years of intense research efforts have failed to identify depression in the brain may indicate that we simply lack the right technology, or it may suggest we have been barking up the wrong tree!

Dr. Joanna Moncrieff,  British Psychiatrist, Author (source)

The most commonly cited evidence to support the chemical imbalance theory is simply that some drugs have been shown to increase and decrease mood in human and animal models, and yes — many antidepressants increase the amounts of serotonin and other neurotransmitters at synapses, but what we fail to realize today is, just because mood can be artificially manipulated with drugs, does not mean the chemical imbalance theory is true. Just because these antidepressants do increase and decrease certain chemical levels in the brain does not prove the chemical imbalance theory of depression.

We simply can’t currently determine if a human being has a chemical imbalance (to whatever extent) or say what neurotransmitters are involved, which is why the chemical imbalance theory of depression remains a theory. It’s not like chemical levels in the brain can accurately be measured or ‘looked at,’ either.

Yet much of the general public still accepts the chemical imbalance theory. Indeed, a survey conducted in 2007 of 262 undergraduates at Cleveland State University found that more than 80 percent of the participants found it “likely” that chemical imbalances cause depression.

“At best, drug-induced affective disturbances can only be considered models for natural disorders, while it remains to be demonstrated that the behavioral changes produced by these drugs have any relation to naturally occurring biochemical abnormalities which might be associated with the illness.” (source)

Keep in mind, as Harvard Medical School points out, there are probably many chemicals involved, working both inside and outside of our nerve cells: “There are millions, even billions, of chemical reactions that make up the dynamic system that is responsible for your mood, perceptions, and how you experience life.”

“The cause of mental disorders such as depression remains unknown. However, the idea that neurotransmitter imbalances cause depression is vigorously promoted by pharmaceutical companies and the psychiatric profession at large.” (source)

Again, theories like the low serotonin one came into existence because scientists were able to observe the effects of drugs on the brain. It was a hypothesis that attempted to explain how drugs could be fixing something, yet whether or not depressed people actually had lower serotonin levels actually remains to be proven. You can read more about the science here.

“The serotonin theory is simply not a scientific statement. It’s a botched theory – a hypothesis that was proven incorrect.” – Dr. Joseph Mercola (source)

Not only is there no solid scientific proof to back up the chemical imbalance theory, many depressed people are not even helped by taking antidepressants like SSRIs. For example, a review done by the University of California in 2009 found that one third of people treated with antidepressants do not improve, and a significant portion of these people remain depressed. As Scientific American observes, “if antidepressants correct a chemical imbalance that underlies depression, all or most depressed people should get better after taking them.”

Depression has one focus, brain chemistry, even though it is a multifaceted issue involving many concerns and many chemicals. Focusing on this one chemical imbalance theory, and then dishing out drugs that actually alter brain chemistry, is shortsighted and dangerous.

“In spite of the enormous amount of money and time that has been spent on the quest to confirm the chemical imbalance theory, direct proof has never materialized.”  (source)

The irony of this situation is hopefully not lost on everyone. The only imbalances we know for sure to exist in the brains of ‘mentally ill’ people are the ones inflicted on them by psychiatric drugs. We are making a false claim that they have biochemical imbalances and then actually giving them biochemical imbalances based on that claim.

Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack of serotonin in the brain. Indeed, their supposed effectiveness is the primary evidence for the chemical imbalance theory. But analyses of the published data and the unpublished data that were hidden by drug companies reveals that most (if not all) of the benefits are due to the placebo effect. Some antidepressants increase serotonin levels, some decrease it, and some have no effect at all on serotonin. Nevertheless, they all show the same therapeutic benefit. Even the small statistical difference between antidepressants and placebos may be an enhanced placebo effect, due to the fact that most patients and doctors in clinical trials successfully break blind. The serotonin theory is as close as any theory in the history of science to having been proved wrong. Instead of curing depression, popular antidepressants may induce a biological vulnerability making people more likely to become depressed in the future.

Related Article: 10 Ways To Increase Dopamine Levels In The Brain 

Irving Kirsch offered the above information in a publication obtained from the US National Library of Medicine. He is the Associate Director of the Program in Placebo Studies and a Lecturer in Medicine at Harvard Medical School. He is also Professor Emeritus of Psychology at the Universities of Hull and Plymouth in the United Kingdom, and a few others in the United States.  Needless to say, he’s done a lot of research, and his revelations above should be read by anybody taking, or considering taking, antidepressant drugs.

The Effectiveness of Anti-Depressant Drugs Compared To Placebo

In a 2002 study conducted by Kirsch and his team of researchers, published in The American Psychological Association’s Prevention & Treatment, it was discovered that 80 percent of the effect of antidepressants, as measured in clinical trials, could be attributed to the placebo effect. The difference between the response of the drugs and the response of the placebo was less than two points on average on a clinical scale that goes from fifty to sixty points. This is a very small difference, and is, according Kirsch, clinically meaningless:

I assumed that antidepressants were effective. As a psychotherapist, I sometimes referred my severely depressed clients for prescriptions of antidepressant drugs. Sometimes the condition of my clients improved when they began taking antidepressants; sometimes it did not. When it did, I assumed it was the effect of the drug that was making them better. Given my long standing interest in the placebo effect, I should have known better, but back then I did not.

Analyzing the data we had found, we were not surprised to find a substantial placebo effect on depression. What surprised us was how small the drug effect was. Seventy-five percent of the improvement in the drug group also occurred when people were give dummy pills with no active ingredient in them.  (source)

To learn more about the placebo effect and access more studies about it, you can refer to this article we published on it a couple of years ago.

“Unpublished Data That That Were Hidden By Drug Companies”

The idea that scientific literature has firmly established the benefits of antidepressants has lost all credibility, thanks in large part to Kirsch and his team. They used the Freedom of Information Act to request that the Food and Drug  Administration (FDA) send data that pharmaceutical companies had sent to it for the process of obtaining approval for multiple antidepressants, which accounted for the bulk of antidepressant prescriptions at the time.  As a result, the researchers were able to obtain data on both published and unpublished trials:

 This turned out to be very important. Almost half of the clinical trials sponsored by the drug companies have not been published (Melander, Ahlqvist-Rastad, Meijer, & Beermann, 2003Turner, Matthews, Linardatos, Tell, & Rosenthal, 2008). The results of the unpublished trials were known only to the drug companies and the FDA, and most of them failed to find a significant benefit of drug over placebo. . . .  [T]he data in the FDA files were the basis upon which the medications were approved. In that sense they have a privileged status. If there is anything wrong with those trials, the medications should not have been approved in the first place. (source)

All in all, the data sent to the researchers by the FDA showed that only 43% of the trials showed a statistically significant  benefit of drug over placebo. The remaining 57% were failed or negative trials.

Many other studies have also demonstrated just how ineffective antidepressants are, as well as how often that fact is obscured by pharmaceutical companies. What’s worse, studies have since determined that anti-depressants can cause real harm to those who take them, and this information is often withheld, too. For example, a study published in The British Medical Journal by researchers at the Nordic Cochrane Center in Copenhagen revealed that pharmaceutical companies were not disclosing all information regarding the results of their drug trials. Researchers looked at documents from 70 different double-blind, placebo-controlled trials of selective serotonin reuptake inhibitors (SSRI) and serotonin and norepinephrine reuptake inhibitors (SNRI) and found that the full extent of serious harm in clinical study reports went unreported. These are the reports sent to major health authorities like the U.S. Food and Drug Administration.

Tamang Sharma, a PhD student at Cochrane and Lead Author of the study, noted that they “found that a lot of the appendices were often only available upon request to the authorities, and the authorities had never requested them,” revealing that she was “actually kind of scared about how bad the actual situation would be if [they] had the complete data.”

Joanna Moncrieff, a psychiatrist and researcher at University College London, elaborates:

[This study] confirms that the full degree of harm of antidepressants is not reported. They are not reported in the published literature, we know that – and it appears that they are not properly reported in clinical study reports that go to the regulators and from the basis of decisions about licensing.

It’s also important to note the pharmaceutical drug aspect into this equation. For (one small out of many) example(s), American psychologist Lisa Cosgrove and others investigated Financial Ties between the Diagnostic and Statistical Manuel of Mental Disorders (DSM) panel members and the pharmaceutical industry. They found that, of the 170 DSM panel members 95 (56%) had one or more financial associations with companies in the pharmaceutical industry. One hundred percent of the members of the panels on ‘mood disorders’ and ‘schizophrenia and other psychotic disorders’ had financial ties to drug companies. The connections are especially strong in those diagnostic areas where drugs are the first line of treatment for mental disorders. In the next edition of the manual, it’s the same thing. (source)(source)

“The DSM appears to be more a political document than a scientific one. Each diagnostic criteria in the DSM is not based on medical science. No blood tests exist for the disorders in the DSM. It relies on judgments from practitioners who rely on the manual.” (11) – Lisa Cosgrove, PhD, Professor of Counseling and School Psychology at the University of Massachusetts, Boston.

The very vocabulary of psychiatry is now defined at all levels by the pharmaceutical industry,” Dr. Irwin Savodnik, an assistant clinical professor of psychiatry at the University of California at Los Angeles (source)

Conclusion & What You Can Try If You’re Not Interested In Drug

Don’t get me wrong, depression is a very real, and a big problem. It’s just the methods commonly used to treat it is what should be called into question.

We’ve written countless amounts of articles on depression, many of which provide alternative method of treatment you can use to help you out. You can read some of them that are listed below:

How Depression Affects Brain Structure & What You Can Do To Change It Back

15 Natural Plant Materials For Treating Depression

5 Things You Can Do To Overcome Depression Using Your Mind

6 Tips To Help You Overcome Anxiety & Depression Without Using Drugs

10 Ways To Increase Dopamine Levels In The Brain

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Advertisement
advertisement - learn more

Alternative News

Legal Challenge Against Forced Vaccination Filed in New York City

Published

on

On April 15, 2019, a legal challenge was filed in the New York State Trial Court by Robert Krakow, Robert F. Kennedy, Jr. and Patricia Finn against the New York City Department of Health and Human Hygiene for their forced Measles-Mumps-Rubella vaccination. The legal team asked for a temporary restraining order against the mandate that the Judge will likely review and provide an ex parte decision. Children’s Health Defense is supporting these efforts.

Last week, Children’s Health Defense reported that the NYC Commissioner of Health declared a public health emergency, ordering all people who live, work or reside in four Brooklyn zip codes to be vaccinated with the Measles-Mumps-Rubella vaccine. Non-compliance with the order is a misdemeanor subject to criminal and civil fines, including imprisonment. Only those with documented immunity, medical contraindications or infants under six months are exempt from the vaccine mandate.

READ THE PETITION
READ THE MEMORANDUM OF LAW
READ THE AFFIRMATION

Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.

advertisement - learn more

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading

Awareness

Magnesium Puts Psychiatric Drugs to Shame for Depression

Published

on

In Brief

  • The Facts:

    This article was written by Sayer Ji, Founder of Greenmedinfo.com where this article first appeared. Posted here with permission.

  • Reflect On:

    Is the priority of our federal health regulatory agencies and pharmaceutical companies human health, or profit? If there are more effective ways to treat several illnesses, why do they never mention them?

Depression is one of the most widely diagnosed conditions of our time, with over 3 million cases in the U.S. every year, and 350 million believed affected worldwide.1 Conventional medicine considers antidepressant drugs first-line treatments, including the newly approved injected postpartum drug costing $34,000 a treatment, to the tune of a 16 billion dollars in global sales by 2023. Despite their widespread use, these drugs are fraught with a battery of serious side effects, including suicidal ideation and completion — the last two things you would hope to see in a condition that already has suicidality as a co-morbidity. For this reason alone, natural, safe, and effective alternatives are needed more than ever before.

While research into natural alternatives for depression is growing daily — GreenMedInfo.com’s Depression database contains 647 studies on over 100 natural substances that have been studied to prevent or treat depression — it is rare to find quality human clinical research on the topic published in well-respected journals. That’s why a powerful study published in PLOS One titled, “Role of magnesium supplementation in the treatment of depression: A randomized clinical trial,” is so promising. Not only is magnesium safe, affordable, and easily accessible, but according to this recent study, effective in treating mild-to moderate symptoms of depression.

While previous studies have looked at the association between magnesium and depression,2-7 this is the first placebo-controlled clinical study to evaluate whether the use of over-the-counter magnesium chloride (248 mg elemental magnesium a day for 6 weeks) improves symptoms of depression.

The study design was a follows:

“ An open-label, blocked, randomized, cross-over trial was carried out in outpatient primary care clinics on 126 adults (mean age 52; 38% male) diagnosed with and currently experiencing mild-to-moderate symptoms with Patient Health Questionnaire-9 (PHQ-9) scores of 5–19. The intervention was 6 weeks of active treatment (248 mg of elemental magnesium per day) compared to 6 weeks of control (no treatment). Assessments of depression symptoms were completed at bi-weekly phone calls. The primary outcome was the net difference in the change in depression symptoms from baseline to the end of each treatment period. Secondary outcomes included changes in anxiety symptoms as well as adherence to the supplement regimen, appearance of adverse effects, and intention to use magnesium supplements in the future. Between June 2015 and May 2016, 112 participants provided analyzable data.”

The study results were as follows:

advertisement - learn more

“Consumption of magnesium chloride for 6 weeks resulted in a clinically significant net improvement in PHQ-9 scores of -6.0 points (CI -7.9, -4.2; P<0.001) and net improvement in Generalized Anxiety Disorders-7 scores of -4.5 points (CI -6.6, -2.4; P<0.001). Average adherence was 83% by pill count. The supplements were well tolerated and 61% of participants reported they would use magnesium in the future. Similar effects were observed regardless of age, gender, baseline severity of depression, baseline magnesium level, or use of antidepressant treatments. Effects were observed within two weeks. Magnesium is effective for mild-to-moderate depression in adults. It works quickly and is well tolerated without the need for close monitoring for toxicity.”

 For perspective, conventional antidepressant drugs are considering to generate an “adequate or complete treatment response” with a PHQ-9 score “decrease of 5 points or more from baseline.” At this level of efficacy, their recommended action is: “Do not change treatment; conduct periodic follow-up.” The magnesium’s score of -6.0 therefore represents the height of success within conventional expectations for a complete response, which is sometimes termed “remission.” In contradistinction, conventional antidepressant drugs result in nearly half of patients discontinuing treatment during the first month, usually due to their powerful and sometimes debilitating side effects.8

To summarize the main study outcomes:

  • There was a clinically significant improvement in both Depression and Anxiety scores.
  • 61% of patients reported they would use magnesium in the future.
  • Similar effects occurred across age, gender, severity of depression, baseline magnesium levels, or use of antidepressant treatments.
  • Effects were observed within two weeks.

 The study authors concluded:

“Magnesium is effective for mild-to-moderate depression in adults. It works quickly and is well tolerated without the need for close monitoring for toxicity.”

Beyond Depression: Magnesium’s Many Health Benefits & Where To Source It

Magnesium is a central player in your body’s energy production, as its found within 300 enzymes in the human body, including within the biologically active form of ATP known as MG-ATP. In fact, there have been over 3,751 magnesium binding sites identified within human proteins, indicating that it’s central nutritional importance has been greatly underappreciated.

Research relevant to magnesium has been accumulating for the past 40 years at a steady rate of approximately 2,000 new studies a year. Our database project has indexed well over 100 health benefits of magnesium thus far.  For the sake of brevity, we will address seven key therapeutic applications for magnesium as follows:

  • Fibromyalgia: Not only is magnesium deficiency common in those diagnosed with fibromyalgia, 9,10 but relatively low doses of magnesium (50 mg), combined with malic acid in the form of magnesium malate, has been clinically demonstrated to improve pain and tenderness in those to which it was administered.11
  • Atrial Fibrillation: A number of studies now exist showing that magnesium supplementation reduce atrial fibrillation, either by itself, or in combination with conventional drug agents.12
  • Diabetes, Type 2: Magnesium deficiency is common in type 2 diabetics, at an incidence of 13.5 to 47.7% according to a 2007 study. 13 Research has also shown that type 2 diabetics with peripheral neuropathy and coronary artery disease have lower intracellular magnesium levels. 14 Oral magnesium supplementation has been shown to reduce plasma fasting glucose and raising HDL cholesterol in patients with type 2 diabetes.15 It has also been shown to improve insulin sensitivity and metabolic control in type 2 diabetic subjects.16
  • Premenstrual Syndrome: Magnesium deficiency has been observed in women affected by premenstrual syndrome.17 It is no surprise therefore  that it has been found to alleviate premenstrual symptoms of fluid retention, 18 as well as broadly reducing associated symptoms by approximately 34% in women, aged 18-45, given 250 mg tablets for a 3-month observational period.20 When combined with B6, magnesium supplementation has been found to improve anxiety-related premenstrual symptoms.19
  • Cardiovascular Disease and Mortality: Low serum magnesium concentrations predict cardiovascular and all-cause mortality.21 There are a wide range of ways that magnesium may confer its protective effects. It may act like a calcium channel blocker,22it is hypotensive,23 it is antispasmodic (which may protect against coronary artery spasm),24 and anti-thrombotic.25 Also, the heart muscle cells are exceedingly dense in mitochondria (as high as 100 times more per cell than skeletal muscle), the “powerhouses” of the cell,” which require adequate magnesium to produce ATP via the citric acid cycle.
  • Migraine Disorders: Blood magnesium levels have been found to be significantly lower in those who suffer from migraine attacks.26,27 A recent Journal of Neural Transmission article titled, “Why all migraine patients should be treated with magnesium,” pointed out that routine blood tests do not accurately convey the true body magnesium stores since less than 2% is in the measurable, extracellular space, “67% is in the bone and 31% is located intracellularly.”28The authors argued that since “routine blood tests are not indicative of magnesium status, empiric treatment with at least oral magnesium is warranted in all migraine sufferers.” Indeed, oral magnesium supplementation has been found to reduce the number of headache days in children experiencing frequent migranous headaches,29and when combined with l-carnitine, is effective at reducing migraine frequency in adults, as well.30
  • Aging: While natural aging is a healthy process, accelerated aging has been noted to be a feature of magnesium deficiency,31especially evident in the context of long space-flight missions where low magnesium levels are associated with cardiovascular aging over 10 times faster than occurs on earth.32 Magnesium supplementation has been shown to reverse age-related neuroendocrine and sleep EEG changes in humans.33 One of the possible mechanisms behind magnesium deficiency associated aging is that magnesium is needed to stabilize DNA and promotes DNA replication. It is also involved in healing up of the ends of the chromosomes after they are divided in mitosis.34

 It is quite amazing to consider the afformentioned side benefits of magnesium consumption or supplementation within the context of the well-known side effects of pharmaceutical approaches to symptom

management of disease. On average, conventional drugs have 75 side effects associated with their use, including lethal ones (albeit sometimes rare). When considering magnesium’s many side benefits

and extremely low toxicity, clearly this fundamental mineral intervention (and dietary requirement) puts pharmaceutical approaches to depression to shame.

Best Sources of Magnesium In The Diet

The best source of magnesium is from food, and one way to identify magnesium-containing foods are those which are green, i.e. chlorophyll rich. Chlorophyll, which enable plants to capture solar energy and convert it into metabolic energy, has a magnesium atom at its center. Without magnesium, in fact, plants could not utilize the sun’s light energy.

Magnesium, however, in its elemental form is colorless, and many foods that are not green contain it as well. The point is that when found complexed with food cofactors, it is absorbed and utilized more efficiently than in its elemental form, say, extracted from limestone in the form of magnesium oxide.

 The following foods contain exceptionally high amounts of magnesium. The portions described are 100 grams, or a little over three ounces.

  • Rice bran, crude (781 mg)
  • Seaweed, agar, dried (770 mg)
  • Chives, freeze-dried (640 mg)
  • Spice, coriander leaf, dried (694 mg)
  • Seeds, pumpkin, dried (535 mg)
  • Cocoa, dry powder, unsweetened (499 mg)
  • Spices, basil, dried (422 mg)
  • Seeds, flaxseed (392 mg)
  • Spices, cumin seed (366 mg)
  • Nuts, brazilnuts, dried (376 mg)
  • Parsley, freeze-dried (372 mg)
  • Seeds, sesame meal (346 mg)
  • Nut, almond butter (303 mg)
  • Nuts, cashew nuts, roasted (273 mg)
  • Soy flour, defatted (290 mg)
  • Whey, sweet, dried (176 mg)
  • Bananas, dehydrated (108 mg)
  • Millet, puffed (106 mg)
  • Shallots, freeze-dried (104 mg)
  • Leeks, freeze-dried (156 mg)
  • Fish, salmon, raw (95 mg)
  • Onions, dehydrated flakes (92 mg)
  • Kale, scotch, raw (88 mg)

 Fortunately, for those who need higher doses, or are not inclined to consume magnesium rich foods, there are supplemental forms commonly available on the market. Keep in mind, for those who wish to take advantage of the side benefit of magnesium therapy, namely, its stool softening and laxative properties, magnesium citrate or oxide will provide this additional feature.

For those looking to maximize absorption and bioavailability magnesium glycinate is ideal, as glycine is the smallest amino acid commonly found chelated to magnesium, and therefore highly absorbable.

For more information on natural solutions to resolving depression, download our free e-book on the topic “21st Century Solutions to Depression.” 

References:

1) World Health Organization. Depression fact sheet no. 369 2012 [cited 2016 December 20]. Available from: http://www.who.int/mediacentre/factsheets/fs369/en/.

2) Jacka FN, Overland S, Stewart R, Tell GS, Bjelland I, Mykletun A. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust N Z J Psychiatry. 2009;43(1):45–52. Pmid:19085527.

3) Huang JH, Lu YF, Cheng FC, Lee JN, Tsai LC. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutrition J. 2012;11(1):41. pmid:22695027; PubMed Central PMCID: PMC3439347.

4) Tarleton EK, Littenberg B. Magnesium intake and depression in adults. J Am Board Fam Med. 2015;28(2):249–56. Pmid:25748766

5) Yary T, Lehto SM, Tolmunen T, Tuomainen T-P, Kauhanen J, Voutilainen S, et al. Dietary magnesium intake and the incidence of depression: a 20-year follow-up study. J Affect Disord. 2016;193:94–8. Pmid:26771950

6) Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362–70. pmid:16542786

7) N Engl J Med. 2000 Dec 28;343(26):1942-50. Managing depression in medical outpatients.

8)  Damiano Piovesan, Giuseppe Profiti, Pier Luigi Martelli, Rita Casadio. 3,751 magnesium binding sites have been detected on human proteins. BMC Bioinformatics. 2012 ;13 Suppl 14:S10. Epub 2012 Sep 7. PMID: 23095498

9) G Moorkens, B Manuel y Keenoy, J Vertommen, S Meludu, M Noe, I De Leeuw. Magnesium deficit in a sample of the Belgian population presenting with chronic fatigue. Magnes Res. 1997 Dec;10(4):329-37. PMID: 9513929

10)  J Eisinger, A Plantamura, P A Marie, T Ayavou. Selenium and magnesium status in fibromyalgia. Magnes Res. 1994 Dec;7(3-4):285-8. PMID: 7786692

11)  I J Russell, J E Michalek, J D Flechas, G E Abraham. Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study. J Rheumatol. 1995 May;22(5):953-8. PMID: 8587088

12) GreenMedInfo.com, Atrial Fibrillation and Magnesium (5 studies)

13)  Phuong-Chi T Pham, Phuong-Mai T Pham, Son V Pham, Jeffrey M Miller, Phuong-Thu T Pham . Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007 Mar;2(2):366-73. Epub 2007 Jan 3. PMID: 17699436

14)  M de Lordes Lima, T Cruz, J C Pousada, L E Rodrigues, K Barbosa, V Canguçu. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998 May;21(5):682-6. PMID: 9589224

15) Y Song, K He, E B Levitan, J E Manson, S Liu. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Cardiovasc Toxicol. 2008;8(3):115-25. Epub 2008 Jul 8. PMID: 16978367

16)  Martha Rodríguez-Morán, Fernando Guerrero-Romero. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003 Apr;26(4):1147-52. PMID: 12663588

17)  F Facchinetti, P Borella, G Sances, L Fioroni, R E Nappi, A R Genazzani. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991 Aug;78(2):177-81. PMID: 2067759

18)  A F Walker, M C De Souza, M F Vickers, S Abeyasekera, M L Collins, L A Trinca. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998 Nov;7(9):1157-65. PMID: 9861593

19)  S Quaranta, M A Buscaglia, M G Meroni, E Colombo, S Cella. Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome. Am J Gastroenterol. 2008 Dec;103(12):2972-6. PMID: 17177579

20) M C De Souza, A F Walker, P A Robinson, K Bolland. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. PMID: 10746516

21) Thorsten Reffelmann, Till Ittermann, Marcus Dörr, Henry Völzke, Markus Reinthaler, Astrid Petersmann, Stephan B Felix. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011 Jun 12. Epub 2011 Jun 12. PMID: 21703623

22) Andrea Rosanoff, Mildred S Seelig. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr. 2004 Oct;23(5):501S-505S. PMID: 15466951

23)  GreenMedInfo.com, Magnesium’s Hypotensive Properties.

24) GreenMedInfo.com, Magnesium’s Antispasmodic Properties.

25) Joen R Sheu, George Hsiao, Ming Y Shen, Yen M Lee, Mao H Yen . Antithrombotic effects of magnesium sulfate in in vivo experiments. Int J Hematol. 2003 May;77(4):414-9. PMID: 12774935

26) Afshin Samaie, Nabiollah Asghari, Raheb Ghorbani, Jafar Arda. Blood Magnesium levels in migraineurs within and between the headache attacks: a case control study. Pan Afr Med J. 2012 ;11:46. Epub 2012 Mar 15. PMID: 22593782

27) Mahnaz Talebi, Dariush Savadi-Oskouei, Mehdi Farhoudi, Solmaz Mohammadzade, Seyyedjamal Ghaemmaghamihezaveh, Akbar Hasani, Amir Hamdi. Relation between serum magnesium level and migraine attacks. Neurosciences (Riyadh). 2011 Oct ;16(4):320-3. PMID: 21983373

28) Alexander Mauskop, Jasmine Varughese. Why all migraine patients should be treated with magnesium. J Neural Transm. 2012 May ;119(5):575-9. Epub 2012 Mar 18. PMID: 22426836

29)  Fong Wang, Stephen K Van Den Eeden, Lynn M Ackerson, Susan E Salk, Robyn H Reince, Ronald J Elin. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Eur J Endocrinol. 2009 Apr;160(4):611-7. Epub 2009 Jan 29. PMID: 12786918

30) Ali Tarighat Esfanjani, Reza Mahdavi, Mehrangiz Ebrahimi Mameghani, Mahnaz Talebi, Zeinab Nikniaz, Abdolrasool Safaiyan. The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res. 2012 Dec ;150(1-3):42-8. Epub 2012 Aug 17. PMID: 22895810

31) David W Killilea, Jeanette A M Maier. A connection between magnesium deficiency and aging: new insights from cellular studies. Magnes Res. 2008 Jun;21(2):77-82. PMID: 18705534

32) GreenMedInfo.com, What We Learned From The Accelerated Aging of Astronauts

33) Katja Held, I A Antonijevic, H Künzel, M Uhr, T C Wetter, I C Golly, A Steiger, H Murck. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry. 2002 Jul;35(4):135-43. PMID: 12163983

34) William J Rowe. Correcting magnesium deficiencies may prolong life. Clin Interv Aging. 2012 ;7:51-4. Epub 2012 Feb 16. PMID: 22379366


Sayer Ji is founder of Greenmedinfo.com, a reviewer at the International Journal of Human Nutrition and Functional Medicine, Co-founder and CEO of Systome Biomed, Vice Chairman of the Board of the National Health Federation, Steering Committee Member of the Global Non-GMO Foundation.


For more info from Greenmedinfo, you can join their newsletter by clicking here.


Link to original article. 

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading

Alternative News

Monsanto Has Been Knowingly Lying About the Safety Of Roundup In Their Ads For Decades

Published

on

In Brief

  • The Facts:

    In 1996, Monsanto was sued by the New York Attorney General based on its false and misleading advertising of Roundup products. Monsanto lost and agreed to stop, but to date they have not stopped those practices anywhere other than New York State.

  • Reflect On:

    How can we use the egregious assault on our health and well-being at the hands of corporations like Bayer-Monsanto to catalyze our awakening and our motivation to build the type of world we would most prefer to live in?

In the wake of a second lawsuit against Monsanto (now owned by Bayer) ruled in favor of defendant Edwin Hardeman to the tune of $80 million, it is starting to look like Monsanto has simply gone to the well too often–a well that they themselves have poisoned. Years of denying that Roundup’s active ingredient glyphosate causes cancer, years of fabricating ‘scientific’ studies to back up this claim, and years of advertising Roundup as safe when they knew it was anything but is now coming back to haunt them, and may eventually put their very survival in danger.

Related CE Article:Bayer (Monsanto) Loses Billions As Another Jury Determines Roundup Herbicide Causes Cancer

What is perhaps most poignant in the settlement is the fact that Hardeman received about $5 million for compensatory damages, based on the fact that his exposure to glyphosate was shown to have caused his cancer, but was awarded an additional $75 million for punitive damages, based on the fact that ‘Monsanto was negligent by not using reasonable care to warn about Roundup’s NHL <Non-Hodgkins Lymphoma> risk.’ (source)

This is telling Monsanto that their most egregious crime was not the fact that their product caused someone’s cancer, but that they intentionally withheld known dangers from the public in their labeling and promotion of the product.

How Do We Know Monsanto Has Been Lying?

How can we say for sure that Monsanto knows that it is promoting false ideas about the safety of Roundup to the public? We only need to dig a little into the case files to see the type of evidence that convinced jurors that they are doing so.

In the first case that Monsanto lost to Dewayne Johnson not too long ago (which we wrote about here and here), the prosecutor revealed that in 1996, Monsanto was sued by the New York Attorney General based on its false and misleading advertising of Roundup products. They ended up agreeing to an ‘Assurance of Discontinuance’ with New York State wherein Monsanto would stop making advertisements that made certain unsubstantiated claims about the safety of Roundup.

advertisement - learn more

A discussion of this piece of evidence between Joe Martino and I is captured in the video below, part of a larger discussion about Bayer-Monsanto and the pharmaceutical industry in our bi-weekly news broadcast ‘The Collective Evolution Show’ available on CETV:

Here is the precise way it was presented in the complaint document of Dewayne Johnson’s lawsuit:

Monsanto has known for decades that it falsely advertises the safety of Roundup

42. In 1996, the New York Attorney General (“NYAG”) filed a lawsuit against Monsanto based on its false and misleading advertising of Roundup products. Specifically, the lawsuit challenged Monsanto’s general representations that its spray-on glyphosate-based herbicides, including Roundup, were “safer than table salt” and “practically non-toxic” to mammals, birds, and fish. Among the representations of the NYAG found deceptive and misleading about the human and environmental safety of Roundup are the following:

A) Remember that environmentally friendly Roundup herbicide is biodegradable. It won’t build up in the soil so you can use Roundup with confidence along customers’ driveways, sidewalks, and fences…

B) And remember that Roundup is biodegradable and won’t build up in the soil. That will give you the environmental confidence you need to use Roundup everywhere you’ve got a weed, brush, edging or trimming problem.

C) Roundup biodegrades into naturally occurring elements.

D) Remember that versatile Roundup herbicide stays where you put it. That means there’s no washing or leaching to harm customers’ shrubs or other desirable vegetation.

E) This non-residual herbicide will not wash or leach in the soil. It…stays where you apply it.

F) You can apply Accord with “confidence because it will stay where you put it,” it bonds tightly to soil particles, preventing leaching. Then, soon after application, soil microorganisms biodegrade Accord into natural products.

G) Glyphosate is less toxic to rats than table salt following accuse oral ingestion.

H) Glyphosate’s safety margin is much greater than required. It has over a 1,000-fold safety margin in food and over a 700-fold safety margin for workers who manufacture it or use it.

I) You can feel good about using herbicides by Monsanto. They carry a toxicity category rating of ‘practically non-toxic’ as it pertains to mammals, birds, and fish.

J) “Roundup can be used where kids and pets will play and break down into natural material.” This ad depicts a person with his head in the ground and a pet dog standing in an area which has been treated with Roundup.

43. On November 19, 1996, Monsanto entered into an Assurance of Discontinuance with NYAG, in which Monsanto agreed, among other things, “to cease and desist from publishing or broadcasting any advertisements [in New York] that represent, directly or by implication” that:

A) its glyphosate-containing pesticide products or any component thereof are safe, non-toxic, harmless, or free from risk.

B) Its glyphosate-containing pesticide products or any component thereof manufactured, formulated, distributed or sold by Monsanto are biodegradable.

C) its glyphosate-containing pesticide products or any component thereof stay where they are applied under all circumstances and will not move through the environment by any means.

D) its glyphosate-containing pesticide products or any component thereof are “good” for the environment or are “known for their environmental characteristics.”

E) glyphosate-containing pesticide products or any component thereof are safer or less toxic than common consumer products other than herbicides.

F) its glyphosate-containing pesticide products or any component thereof night be classified as “practically non-toxic.”

44. Monsanto did not alter its advertising in the same manner in any state other than New York, and on information and belief still has not done so today.

One of the reasons this is so compelling is that it shows Monsanto being forced to acknowledge that it was using deceptive practices, but that it made absolutely no effort to stop this deceptive practice in any other state than the one they were forced to. It is evidence like this that is starting to make people realize that we can no longer give corporations the benefit of the doubt when it comes to their claims that their products are safe for human beings and for the environment.

The Takeaway

As information of this kind comes more into the public eye, and as we become more aware that corporations are willfully putting public health at risk simply for the sake of profit, our collective wheels will start turning with thoughts about the type of world we want to live in, imbued with a sense of urgency around creating a system within which human safety and health are much more highly valued.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading
advertisement - learn more
advertisement - learn more

Video

Pod